- Home
- BWFG vs AVIR Comparison
BWFG vs AVIR Comparison
Compare BWFG & AVIR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | BWFG | AVIR |
|---|---|---|
| Founded | 2002 | 2012 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Medicinal Chemicals and Botanical Products |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 525.2M | 429.1M |
| IPO Year | 2014 | 2020 |
Fundamental Metrics
Financial Performance| Metric | BWFG | AVIR |
|---|---|---|
| Price | $65.27 | $5.10 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 3 | 3 |
| Target Price | ★ $69.50 | $9.42 |
| AVG Volume (30 Days) | 56.6K | ★ 245.7K |
| Earning Date | 10-22-2026 | 11-11-2026 |
| Dividend Yield | ★ 1.24% | N/A |
| EPS Growth | ★ 261.79 | 3.00 |
| EPS | ★ 2.95 | N/A |
| Revenue | $2,826,000.00 | ★ $351,367,000.00 |
| Revenue This Year | $20.01 | N/A |
| Revenue Next Year | $6.51 | N/A |
| P/E Ratio | $22.00 | ★ N/A |
| Revenue Growth | ★ 43.96 | N/A |
| 52 Week Low | $40.45 | $2.81 |
| 52 Week High | $69.59 | $6.45 |
Technical Indicators
Market Signals| Indicator | BWFG | AVIR |
|---|---|---|
| Relative Strength Index (RSI) | N/A | 46.26 |
| Support Level | N/A | $5.01 |
| Resistance Level | N/A | $5.76 |
| Average True Range (ATR) | 0.00 | 0.19 |
| MACD | 0.00 | -0.03 |
| Stochastic Oscillator | 0.00 | 25.19 |
Price Performance
Historical ComparisonAbout BWFG Bankwell Financial Group Inc.
Bankwell Financial Group Inc is a bank holding company, engaged in providing financial products and services. It offers products related to commercial lending, retail lending, depository services, and others. The bank's commercial lending products includes owner-occupied commercial real estate loans, commercial real estate investment loans, commercial loans to small and mid-sized businesses and real estate construction and development loans. The retail lending products include residential mortgage loans, home equity lines of credit, and consumer installment loans. Its depository products include checking, savings, money market, certificates of deposit, noninterest-bearing demand, and time deposits.
About AVIR Atea Pharmaceuticals Inc.
Atea Pharmaceuticals Inc is a late-stage clinical biopharmaceutical company focused on the discovery, development, and commercialization of oral antiviral therapies for serious viral diseases. The company's pipeline includes a regimen of bemnifosbuvir and ruzasvir for the treatment of hepatitis C virus (HCV) infection and AT-587 for the treatment of hepatitis E virus (HEV) infection.